Why Partner with Current Oncology?
Current Oncology is your premier partner for reaching a diverse, growing community of engaged and knowledgeable oncologists, specialists in allied disciplines, residents, nurses, family physicians, and patients and their families throughout Canada. Current Oncology continues to draw the attention of these professionals and the interested public because of its combination of integrity, credibility, and high-value content as exemplified in
- an editorial board that includes some of the most respected researchers, authors, teachers, and practitioners in the field;
- status as the only peer-reviewed journal covering Canadian oncologic practice in addition to reports and reviews of studies and primary research of global significance;
- an academic focus and a commitment to the research model espoused by the National Cancer Institute of Canada and the Canadian Institutes of Health Research; and
- a consistently high quality of submissions, leading to acceptance of the journal for indexing in the U.S. National Library of Medicine’s PubMed database, PubMed Central, and Excerpta Medica, among others.
- an impact factor of 2.473, as published in the 2011 Journal Citation Reports, Science Edition (Thomson Reuters, 2012).
Your company or organization can work with Current Oncology publisher Multimed Inc. to leverage their over 30 years of experience in medical publishing to achieve your communication goals. Current Oncology offers a variety of partnering opportunities for disseminating your message; developing relationships with the research, practice, or patient communities; or publishing your own innovations and discoveries.
Print & Electronic Advertising
Achieve the exposure your organization needs. Make your product or service highly visible to the oncology market. Recruit from, or otherwise harness, a qualified pool of committed professionals. View our 2013 Media Kit for information regarding rates, circulation, mechanical requirements, and insertion & material dates.
Publishing with Current Oncology
Provide valuable and up-to-date educational material to our readership and oncology community by publishing with Current Oncology. All articles submitted to the journal undergo our peer review process and must be accepted prior to publication. View our 2013 Media Kit for information about standard and fast track publication fees.
Professional Supplement Sponsorship
Current Oncology has published a variety of supplements on a range of topics, all dedicated to providing in-depth information to our readership. Supplements provide valuable up-to-date educational material to the Canadian oncology community.
Professional supplements are an ideal way to publish:
- Meeting/conference proceedings
- Abstracts from meetings/conferences
- Results of meetings or seminars
- Review articles on a dedicated subject
- Consensus guidelines and statements
For organizers seeking to publish material as a supplement to Current Oncology, the process involves the following:
Role of the Sponsor: Provide a brief summary of the work to be published, including authors, guest editor (if applicable) and topic. If the supplement project is accepted by our editorial team, the authors will be asked to submit their manuscript to our online submission system for peer review. The sponsoring company will be acknowledged as the provider of an unrestricted educational grant.
Role of the Current Oncology Team: Liaise with suggested authors or contact qualified authors from the oncology community. Arrange for submission, peer review and professional copy editing of the manuscripts. Manage any contact with the author and the editorial board. Publish the supplement in both print and online, and distribute the published article to the Current Oncology readership.
Article Reprints and Licensing
Commerical reprint are an excellent way for companies to promote and inform the medical community about their activities and products. Current Oncology's reprints are produced to the highest standards of quality, with specially designed covers and customization options including an advertising or promotional message, extra information or a company logo.
Articles from Current Oncology can be translated into any language and produced as translated reprints. Licensing and/or royalty arrangements can be made in order to give your company the flexibility you require.
Please click here for further information about reprints and licensing.
Current Oncology Bulk Subscriptions
Multimed is pleased to offer special bulk print subscription rates to Current Oncology. Bulk subscriptions are an ideal way to keep members of your organization up to date on the latest research within the Canadian Oncology community. Your sales team may also deliver the journal to ensure the medical practitioners they serve receive the timely information and research published in Current Oncology.
Please click here for further information about bulk subscriptions.
For print and electronic advertising, sponsored articles, and bulk subscriptions contact:
66 Martin Street,
Milton, ON L9T 2R2
For supplements, reprints and licensing contact:
66 Martin Street,
Milton, ON L9T 2R2
Copyright © 2013 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)